Beaird Harris Wealth Management’s HOOKIPA Pharma HOOK Stock Holding History

Beaird Harris Wealth Management’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9	Closed	-$57	–	613
2023 Q3	$57	Hold	9	–	–	﹤0.01%	446
2023 Q2	$81	Hold	9	–	–	﹤0.01%	448
2023 Q1	$68	Hold	9	–	–	﹤0.01%	475
2022 Q4	$75	Hold	9	–	–	﹤0.01%	726
2022 Q3	$0	Hold	9	–	–	﹤0.01%	507
2022 Q2	$0	Hold	9	–	–	﹤0.01%	497
2022 Q1	$0	Hold	9	–	–	﹤0.01%	651
2021 Q4	$0	Buy	+9	New	+$362	﹤0.01%	654

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Beaird Harris Wealth Management's HOOK Position: Q4 2023 in Review

Beaird Harris Wealth Management sold out of HOOKIPA Pharma (HOOK) in Q4 2023, closing a stake of 9 shares — an estimated $57 sold.

Beaird Harris Wealth Management first reported a position in HOOK in Q4 2021 and held it in 8 quarters. The position peaked at $81 in Q2 2023. 41 funds tracked by Wall St. Rank hold HOOK as of Q4 2023.

Beaird Harris Wealth Management reported no remaining HOOKIPA Pharma position as of Q4 2023 after selling out during the quarter.
Beaird Harris Wealth Management sold 9 HOOKIPA Pharma shares in Q4 2023, an estimated $57.
Beaird Harris Wealth Management first reported a position in HOOKIPA Pharma in Q4 2021 and held it in 8 quarters.
Beaird Harris Wealth Management's HOOKIPA Pharma position peaked at $81 in Q2 2023.
41 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2023.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2023, filed 27 Feb 2024.